Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells

Robert Davidson, Lydia Shajenko, Theodore S. Donta

Research output: Contribution to journalArticle

Abstract

The neurodegenerative pathology observed in Alzheimer's Disease (AD) has been partially attributed to the neurotoxic effects of the amyloid beta-peptide (AβP), although the mechanisms underlying this neurotoxicity are unknown. Since AβP is capable of forming cation channels in lipid bilayers, it is possible that the neurotoxic effects on neurons may be mediated by a cation flux. We have used patch-clamp recording techniques to study the effects of AβP on cation currents in differentiated mouse N1E-115 neuroblastoma cells. In whole-cell recordings, incubation of cells with AβP for 24 h significantly increased the median peak inward current from -201.8 pA to -352.0 pA, and shifted the voltage at peak current (Vpeak) and that of current activation (Vact) towards more positive potentials. For untreated cells, median Vpeak was 1.7 mV and Vact was -28.9 mV, vs. 10.5 mV and -24.7 mV in AβP-treated cells. Incubation with the reverse sequence AβP(40-1) or AβP(25-35) did not produce significant changes in the amplitude or kinetic behavior of the inward current. At the single channel level, AβP added to the pipette increased the open probability of cation-conducting ion channels. As determined by cell viability counts, both AβP(1-40) and the AβP(25-35) fragment had neurotoxic effects; within 24 h, addition of AβP reduced the number of viable cells by more than 50%. It is suggested that the neurotoxic effects of AβP may be mediated by its ability to form cation channels de novo and/or alter the activity of cation channels already present in the cell membrane.

Original languageEnglish (US)
Pages (from-to)324-327
Number of pages4
JournalBrain Research
Volume643
Issue number1-2
DOIs
StatePublished - Apr 18 1994

Fingerprint

Nimodipine
Amyloid beta-Peptides
Barium
Neuroblastoma
Cations
Patch-Clamp Techniques
Cell Count
Lipid Bilayers
Ion Channels
Cell Survival
Alzheimer Disease
Cell Membrane
Pathology
Neurons

Keywords

  • Alzheimer's disease
  • Amyloid β-peptide
  • Calcium channel
  • Neuroblastoma cell
  • Nimodipine
  • Patch clamp

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. / Davidson, Robert; Shajenko, Lydia; Donta, Theodore S.

In: Brain Research, Vol. 643, No. 1-2, 18.04.1994, p. 324-327.

Research output: Contribution to journalArticle

@article{7e53c896c95b4231accc141d2ce24fec,
title = "Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells",
abstract = "The neurodegenerative pathology observed in Alzheimer's Disease (AD) has been partially attributed to the neurotoxic effects of the amyloid beta-peptide (AβP), although the mechanisms underlying this neurotoxicity are unknown. Since AβP is capable of forming cation channels in lipid bilayers, it is possible that the neurotoxic effects on neurons may be mediated by a cation flux. We have used patch-clamp recording techniques to study the effects of AβP on cation currents in differentiated mouse N1E-115 neuroblastoma cells. In whole-cell recordings, incubation of cells with AβP for 24 h significantly increased the median peak inward current from -201.8 pA to -352.0 pA, and shifted the voltage at peak current (Vpeak) and that of current activation (Vact) towards more positive potentials. For untreated cells, median Vpeak was 1.7 mV and Vact was -28.9 mV, vs. 10.5 mV and -24.7 mV in AβP-treated cells. Incubation with the reverse sequence AβP(40-1) or AβP(25-35) did not produce significant changes in the amplitude or kinetic behavior of the inward current. At the single channel level, AβP added to the pipette increased the open probability of cation-conducting ion channels. As determined by cell viability counts, both AβP(1-40) and the AβP(25-35) fragment had neurotoxic effects; within 24 h, addition of AβP reduced the number of viable cells by more than 50{\%}. It is suggested that the neurotoxic effects of AβP may be mediated by its ability to form cation channels de novo and/or alter the activity of cation channels already present in the cell membrane.",
keywords = "Alzheimer's disease, Amyloid β-peptide, Calcium channel, Neuroblastoma cell, Nimodipine, Patch clamp",
author = "Robert Davidson and Lydia Shajenko and Donta, {Theodore S.}",
year = "1994",
month = "4",
day = "18",
doi = "10.1016/0006-8993(94)90041-8",
language = "English (US)",
volume = "643",
pages = "324--327",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells

AU - Davidson, Robert

AU - Shajenko, Lydia

AU - Donta, Theodore S.

PY - 1994/4/18

Y1 - 1994/4/18

N2 - The neurodegenerative pathology observed in Alzheimer's Disease (AD) has been partially attributed to the neurotoxic effects of the amyloid beta-peptide (AβP), although the mechanisms underlying this neurotoxicity are unknown. Since AβP is capable of forming cation channels in lipid bilayers, it is possible that the neurotoxic effects on neurons may be mediated by a cation flux. We have used patch-clamp recording techniques to study the effects of AβP on cation currents in differentiated mouse N1E-115 neuroblastoma cells. In whole-cell recordings, incubation of cells with AβP for 24 h significantly increased the median peak inward current from -201.8 pA to -352.0 pA, and shifted the voltage at peak current (Vpeak) and that of current activation (Vact) towards more positive potentials. For untreated cells, median Vpeak was 1.7 mV and Vact was -28.9 mV, vs. 10.5 mV and -24.7 mV in AβP-treated cells. Incubation with the reverse sequence AβP(40-1) or AβP(25-35) did not produce significant changes in the amplitude or kinetic behavior of the inward current. At the single channel level, AβP added to the pipette increased the open probability of cation-conducting ion channels. As determined by cell viability counts, both AβP(1-40) and the AβP(25-35) fragment had neurotoxic effects; within 24 h, addition of AβP reduced the number of viable cells by more than 50%. It is suggested that the neurotoxic effects of AβP may be mediated by its ability to form cation channels de novo and/or alter the activity of cation channels already present in the cell membrane.

AB - The neurodegenerative pathology observed in Alzheimer's Disease (AD) has been partially attributed to the neurotoxic effects of the amyloid beta-peptide (AβP), although the mechanisms underlying this neurotoxicity are unknown. Since AβP is capable of forming cation channels in lipid bilayers, it is possible that the neurotoxic effects on neurons may be mediated by a cation flux. We have used patch-clamp recording techniques to study the effects of AβP on cation currents in differentiated mouse N1E-115 neuroblastoma cells. In whole-cell recordings, incubation of cells with AβP for 24 h significantly increased the median peak inward current from -201.8 pA to -352.0 pA, and shifted the voltage at peak current (Vpeak) and that of current activation (Vact) towards more positive potentials. For untreated cells, median Vpeak was 1.7 mV and Vact was -28.9 mV, vs. 10.5 mV and -24.7 mV in AβP-treated cells. Incubation with the reverse sequence AβP(40-1) or AβP(25-35) did not produce significant changes in the amplitude or kinetic behavior of the inward current. At the single channel level, AβP added to the pipette increased the open probability of cation-conducting ion channels. As determined by cell viability counts, both AβP(1-40) and the AβP(25-35) fragment had neurotoxic effects; within 24 h, addition of AβP reduced the number of viable cells by more than 50%. It is suggested that the neurotoxic effects of AβP may be mediated by its ability to form cation channels de novo and/or alter the activity of cation channels already present in the cell membrane.

KW - Alzheimer's disease

KW - Amyloid β-peptide

KW - Calcium channel

KW - Neuroblastoma cell

KW - Nimodipine

KW - Patch clamp

UR - http://www.scopus.com/inward/record.url?scp=0028178530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028178530&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)90041-8

DO - 10.1016/0006-8993(94)90041-8

M3 - Article

VL - 643

SP - 324

EP - 327

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -